ES2061682T3 - Cisteina proteinasas, produccion y uso. - Google Patents

Cisteina proteinasas, produccion y uso.

Info

Publication number
ES2061682T3
ES2061682T3 ES88309842T ES88309842T ES2061682T3 ES 2061682 T3 ES2061682 T3 ES 2061682T3 ES 88309842 T ES88309842 T ES 88309842T ES 88309842 T ES88309842 T ES 88309842T ES 2061682 T3 ES2061682 T3 ES 2061682T3
Authority
ES
Spain
Prior art keywords
production
enzymes
disclosed
distinct
cysteine proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88309842T
Other languages
English (en)
Inventor
Andrew D Rowan
David J Buttle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Application granted granted Critical
Publication of ES2061682T3 publication Critical patent/ES2061682T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/63Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from plants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/13Burn treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

UNA CISTEINA - PROTEINASA CARACTERIZADA PORQUE ES INMUNOLOGICAMENTE DISTINTA, TIENE UNA MASA MOLECULAR DE ALREDEDOR DE 25000 Y UNA CARGA NETA DISTINTA. TALES ENZIMAS SON ANANAIN Y COMOSAIN QUE SE PUEDEN DISTINGUIR POR SUS ESPECIFICIDADES PARA LAGUNOS SUSTRATOS SINTETICOS. TAMBIEN SE INCLUYE UN PROCESO PARA SU PRODUCCION QUE COMPRENDE LA SEPARACION DE MATERIAL DE UNA PLANTA DE ELABORACION DE PINA Y SU PURIFICACION. ESTAS ENZIMAS SE PUEDEN EMPLEAR EN EL DESBRIDAMIENTO DE TEJIDOS DE COSTRAS DE HERIDAS.
ES88309842T 1987-10-22 1988-10-20 Cisteina proteinasas, produccion y uso. Expired - Lifetime ES2061682T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878724728A GB8724728D0 (en) 1987-10-22 1987-10-22 Cysteine proteinase

Publications (1)

Publication Number Publication Date
ES2061682T3 true ES2061682T3 (es) 1994-12-16

Family

ID=10625712

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88309842T Expired - Lifetime ES2061682T3 (es) 1987-10-22 1988-10-20 Cisteina proteinasas, produccion y uso.

Country Status (11)

Country Link
US (1) US5106621A (es)
EP (1) EP0313346B1 (es)
JP (1) JP2644006B2 (es)
AT (1) ATE102248T1 (es)
AU (1) AU628790B2 (es)
CA (1) CA1319121C (es)
DE (1) DE3888082T2 (es)
DK (1) DK589388A (es)
ES (1) ES2061682T3 (es)
GB (1) GB8724728D0 (es)
IL (1) IL88078A (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8821049D0 (en) * 1988-09-08 1988-10-05 Health Lab Service Board Method & composition for treatment & prevention of viral infections
IL105699A0 (en) * 1992-06-26 1993-09-22 Genzyme Corp Hydrophilic creams for delivery of therapeutic agents
JP3221997B2 (ja) * 1993-03-26 2001-10-22 株式会社東芝 画像処理装置
US5387517A (en) * 1994-03-23 1995-02-07 Ethicon, Inc. Thiol activated protease from stem bromelain for treating devitalized tissue
US5935572A (en) * 1997-01-10 1999-08-10 Collaborative Laboratories, Inc. Composition containing protease separate from glycosidase for removing nits in treating lice infestation
CN1252101A (zh) 1997-02-25 2000-05-03 科特克斯(英国)有限公司 菠萝蛋白酶成分
WO1998038319A1 (en) * 1997-02-25 1998-09-03 Cortecs (Uk) Limited Component of bromelain
US20020102253A1 (en) 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
US6548556B2 (en) 2000-12-27 2003-04-15 Healthpoint, Ltd. Stable enzymatic wound debrider
US7364565B2 (en) 2001-07-27 2008-04-29 Ramot At Tel Aviv University Ltd. Controlled enzymatic removal and retrieval of cells
AU2003222418B2 (en) * 2002-04-23 2008-10-23 Mediwound, Ltd. Apparatus and methods for enzymatic escharotomy in burn induced compartment syndrome
AU2003287105A1 (en) * 2002-10-10 2004-05-04 Verenium Corporation Proteases, nucleic acids encoding them and methods for making and using them
IL165334A0 (en) 2004-11-22 2006-01-15 Mediwound Ltd Debriding composition from bromelain and methods of producing same
AT502391B1 (de) 2005-09-20 2007-03-15 Univ Innsbruck Inst Fuer Umwel Verfahren zur behandlung von ammoniumhaltigem abwasser
US20110239327A1 (en) * 2007-01-16 2011-09-29 Rosane Curtis Nematicidal Effects of Cysteine Proteinases and Methods of Use Thereof to Treat Nematode Infestation
EP2226382A1 (en) 2009-03-03 2010-09-08 B.R.A.I.N. Biotechnology Research and Information Network AG Protease for wound conditioning and skin care
CA2842291C (en) * 2011-07-20 2020-09-15 Mediwound Ltd. Proteolytic extract from bromelain for the treatment of connective tissue disorders
US10058596B2 (en) 2011-12-20 2018-08-28 Kci Licensing, Inc. Composition for enzymatic debridement
US20150259370A1 (en) * 2014-03-11 2015-09-17 Ecotech Development LLC Integrated process extraction of pineapple biomass into fibers and natural products
AU2016308267A1 (en) * 2015-08-20 2018-03-29 Anatara Lifesciences Limited Enzymatic fractions with anti-inflammatory activity
ES2909565T3 (es) * 2016-01-31 2022-05-09 Mediwound Ltd Composición desbridante para el tratamiento de heridas

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3002891A (en) * 1958-12-12 1961-10-03 Pineapple Res Inst Of Hawaii Process for the preparation of pineapple stem bromelain
US2950227A (en) * 1959-06-05 1960-08-23 Schering Ag Ferments of the papain type and process of making same
US4226854A (en) * 1974-01-08 1980-10-07 Gerold K. V. Klein Debridement of devitalized tissue with hydrolytic enzyme product
US4197291A (en) * 1974-01-08 1980-04-08 Gerold K. V. Klein Hydrolytic enzyme material
US4329430A (en) * 1979-06-04 1982-05-11 Klein Gerold K V Enzyme mixture
US4286064A (en) * 1979-11-05 1981-08-25 Riker Laboratories, Inc. Process for isolating active debriding agent from bromelain
US4361551A (en) * 1979-11-05 1982-11-30 Riker Laboratories, Inc. Method of enzymatic debridement
WO1981001242A1 (en) * 1979-11-05 1981-05-14 Riker Laboratories Inc Method of enzymatic debridement
US4645668A (en) * 1983-08-04 1987-02-24 Biospecifics, Nv Method for the prevention and treatment of scars with enzymes

Also Published As

Publication number Publication date
EP0313346B1 (en) 1994-03-02
AU2405988A (en) 1989-06-08
DE3888082T2 (de) 1994-06-09
IL88078A0 (en) 1989-06-30
IL88078A (en) 1993-08-18
DE3888082D1 (de) 1994-04-07
CA1319121C (en) 1993-06-15
JPH0216977A (ja) 1990-01-19
GB8724728D0 (en) 1987-11-25
JP2644006B2 (ja) 1997-08-25
DK589388A (da) 1989-04-23
EP0313346A3 (en) 1990-05-09
DK589388D0 (da) 1988-10-21
US5106621A (en) 1992-04-21
AU628790B2 (en) 1992-09-24
ATE102248T1 (de) 1994-03-15
EP0313346A2 (en) 1989-04-26

Similar Documents

Publication Publication Date Title
ES2061682T3 (es) Cisteina proteinasas, produccion y uso.
DE68923123D1 (de) Herstellung von Proteinen.
EP0295959A3 (en) Sulphur-rich protein from bertholletia excelsa h.b.k.
FI862756A (fi) Fibroektiner.
IT1221776B (it) Processo per la preparazione di 1,2 difluoroetano e di 1,1,2 trifluoroetano
ATE97421T1 (de) Gentechnologisch hergestellter pankreatischer sekretorischer trypsininhibitor und seine varianten.
DE3855449D1 (de) DNS-Klone von menschlichem Thrombomodulin
EP0309550A4 (en) PROTEOLYTIC ENZYMS.
FI945626A (fi) Menetelmä 2,2-difluoriketeenisilyyliasetaalien ja alfa, alfa-difluori-beta-silyylioksi-1,3-dioksolaani-4-propaanihappoestereiden valmistamiseksi
FR2632638B1 (fr) Procede de fabrication d'oxydes d'amines
DE3885588D1 (de) Photopolymerisierbares Gemisch und daraus hergestelltes Aufzeichnungsmaterial.
UA26870C2 (uk) Спосіб підвищеhhя продукуваhhя протеїhу с, спосіб підвищеhhя рівhя його модифікації
MY110997A (en) Novel aminopeptidase, processes for the preparation of aminipeptidase and protien therefrom
DK145988A (da) Genteknologisk fremstillet 140 kd-antigen af plasmodium falciparum og dettes anvendelse
GB8808356D0 (en) Substituted silicon nitride material & method of production thereof
EP0236040A3 (en) Amino acid modified prourokinase and method of preparation
IT9021609A0 (it) Impianto per la produzione di calzature e procedimento per l'impiego di detto impianto
FR2328694A1 (fr) Procede de preparation d'un peptide en presence d'un enzyme thio proteinase ou serine proteinase
DK120687D0 (da) Hoej-produktiv bakterie-fermentation samt fremgangsmaade til fremstilling af proteinmateriale
WO1990010006A3 (de) NEUE β-METHOXYACRYLATE, IHRE HERSTELLUNG UND VERWENDUNG
PT88578A (pt) Process for the manufacture of 2,6-methanopyrrolo-3-benzazocines of intermediates useful for their manufacture and of pharmaceutical compositions containing them
HU911919D0 (en) Process and recombinant dna for the production of chimaera antibodies
ATE66453T1 (de) Herstellung von zwischenverbindungen fuer leukotrien-antagonisten.
JPS5549361A (en) Novel compound having benzyloxycarbonyl group and its preparation
DE3888078T2 (de) Veränderungsverfahren für Peptide und Proteine.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 313346

Country of ref document: ES